The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rationale and preclinical development of LEAF-1401 and LEAF-1701: A novel class of potent next generation antifolates.
 
Victor M. Moyo
Employment - L.E.A.F. Pharmaceuticals; Merrimack
Leadership - L.E.A.F. Pharmaceuticals
Stock and Other Ownership Interests - Diffusion Pharmaceuticals; L.E.A.F. Pharmaceuticals; Merrimack
Consulting or Advisory Role - Diffusion Pharmaceuticals; Diffusion Pharmaceuticals (Inst); L.E.A.F. Pharmaceuticals; Merrimack
Patents, Royalties, Other Intellectual Property - L.E.A.F. Pharmaceuticals; Merrimack
Travel, Accommodations, Expenses - Diffusion Pharmaceuticals; L.E.A.F. Pharmaceuticals; Merrimack
 
Zhenghong Xu
Employment - L.E.A.F. Pharmaceuticals
Patents, Royalties, Other Intellectual Property - L.E.A.F. Pharmaceuticals
 
Kaniz Khalifa
Employment - L.E.A.F. Pharmaceuticals
Stock and Other Ownership Interests - L.E.A.F. Pharmaceuticals
Patents, Royalties, Other Intellectual Property - L.E.A.F. Pharmaceuticals
 
Nishant Gandhi
Employment - L.E.A.F. Pharmaceuticals
Patents, Royalties, Other Intellectual Property - I have patents pending with L.E.A.F. Pharmaceuticals.
 
Bolin Geng
No Relationships to Disclose
 
Navreet Dhindsa
Employment - L.E.A.F. Pharmaceuticals
Leadership - L.E.A.F. Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Merrimack
 
Clet Niyikiza
Employment - L.E.A.F. Pharmaceuticals
Leadership - L.E.A.F. Pharmaceuticals
Stock and Other Ownership Interests - AVEO; L.E.A.F. Pharmaceuticals; Merrimack
Patents, Royalties, Other Intellectual Property - L.E.A.F. Pharmaceuticals; Merrimack
Expert Testimony - Lilly